We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ADMA market cap is 4.5B. The company's latest EPS is USD 0.8280 and P/E is 22.80.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 81.88M | 107.19M | 119.84M | 117.55M | 114.8M |
| Operating Income | 21.82M | 39.2M | 39.64M | 38.32M | 34.88M |
| Net Income | 17.81M | 32.06M | 35.91M | 111.9M | 26.9M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 42.22M | 80.94M | 154.08M | 258.22M | 426.45M |
| Operating Income | -64.91M | -58.37M | -39.37M | 21.63M | 138.98M |
| Net Income | -75.75M | -71.65M | -65.9M | -28.24M | 197.67M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 350.88M | 376.4M | 390.62M | 488.68M | 510.57M |
| Total Liabilities | 197.17M | 188.13M | 158.73M | 139.66M | 137.15M |
| Total Equity | 153.71M | 188.27M | 231.89M | 349.02M | 373.42M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 207.67M | 276.25M | 348.46M | 329.18M | 488.68M |
| Total Liabilities | 119.42M | 135.08M | 196.49M | 193.98M | 139.66M |
| Total Equity | 88.25M | 141.17M | 151.97M | 135.21M | 349.02M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.22M | 43.43M | 68.46M | 118.67M | -19.68M |
| Investing | -2.36M | -4.73M | -5.83M | -8.58M | -4.72M |
| Financing | -1.45M | -1.81M | -27.28M | -58.3M | -7.13M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -102M | -112.37M | -59.51M | 8.8M | 118.67M |
| Investing | -12.73M | -13.51M | -13.91M | -4.98M | -8.58M |
| Financing | 143.9M | 121.05M | 108.85M | -38.99M | -58.3M |
| Market Cap | 4.5B |
| Price to Earnings Ratio | 22.80 |
| Price to Sales Ratio | 10.57 |
| Price to Cash Ratio | 43.69 |
| Price to Book Ratio | 12.91 |
| Dividend Yield | - |
| Shares Outstanding | 238.73M |
| Average Volume (1 week) | 3.17M |
| Average Volume (1 Month) | 2.39M |
| 52 Week Change | 78.26% |
| 52 Week High | 25.67 |
| 52 Week Low | 10.33 |
| Spread (Intraday) | 0.03 (0.16%) |
| Company Name | Adma Biologics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.admabiologics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
